Amarna Therapeutics

Developer of immune-modulating gene therapies for rare and prevalent autoimmune diseases and genetic diseases

placeLeiden, South Holland, Netherlands calendar_todayFounded 2008 groups30 employees language amarnatherapeutics.com

Social engagement

Social engagement: 3.2K social following, 2 posts in the last 12 months — below the industry typical range.

Investor mix

3 investors on record; lead investors include Flerie.

Investor typeCountShare
Venture capital133%
Other / undisclosed267%
Coming soon